Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vogliright GM 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Celera Healthcare Pvt. Ltd.

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Vogliright GM 2mg/500mg/0.2mg Tablet

Diabex Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, effectively regulating blood glucose. Diabex Trio should be administered with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by symptoms like sweating, dizziness, headache, and trembling. Prompt glucose intake (e.g., sugary foods, fruit juice) is essential. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before using Diabex Trio if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Uses of Vogliright GM 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Vogliright GM 2mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Vogliright GM 2mg/500mg/0.2mg tablet whole; do not crush, chew, or break it. Administer on an empty stomach.

Common Side effects of Vogliright GM 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Vogliright GM 2mg/500mg/0.2mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Vogliright GM 2mg/500mg/0.2mg tablet whole; avoid chewing, crushing, or fracturing it. Consume it on an empty stomach.

How Vogliright GM 2mg/500mg/0.2mg Tablet works:

The tablet Vogliright GM, containing 2mg/500mg/0.2mg of a triple-action antidiabetic formulation, combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vogliright GM 2mg/500mg/0.2mg Tablet with alcohol is contraindicated due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Pregnancy use of Vogliright GM 2mg/500mg/0.2mg Tablet may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Vogliright GM 2mg/500mg/0.2mg Tablets is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Vogliright GM 2mg/500mg/0.2mg tablets is likely inadvisable for individuals with kidney impairment and should be omitted. Medical advice is necessary. Furthermore, its administration is contraindicated in patients experiencing severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Vogliright GM 2mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Vogliright GM 2mg/500mg/0.2mg Tablet :

Should you forget a Vogliright GM 2mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vogliright GM 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Vogliright GM 2mg/500mg/0.2mg Tablet

Vogliright GM 2mg/500mg/0.2mg Tablet combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This treatment improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This combination is unsuitable for type 1 diabetes.
Vogliright GM 2mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, abdominal pain, headache, rash, and respiratory infection.
Vogliright GM 2mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any ingredient or excipient. Their use is also contraindicated in individuals with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Vogliright GM 2mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Vogliright GM 2mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vogliright GM 2mg/500mg/0...
74
MRP 90
18% off